Two-year results with 166Holmium-phytate treatment of chronic synovitis.: Phase I-IIa, randomized, increasing dosage, single-blind, placebo-controlled comparative study

被引：0
|
作者：
Szentesi, M
Takács, S
Farbaky, Z
Nagy, E
Környei, J
Antalffy, M
Törkö, J
Tóth, G
Jánoki, G
Balogh, L
Géher, P
机构：
[1] Semmelweis Univ, H-1085 Budapest, Hungary
[2] Inst Isotopes Co Ltd, Budapest, Hungary
[3] Natl FJC Res Inst Radiobiol & Radiohyg, Budapest, Hungary
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2004年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S478 / S478
页数：1
相关论文
共 50 条
  • [21] The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
    Terkeltaub, R.
    Sundy, J. S.
    Schumacher, H. R.
    Murphy, F.
    Bookbinder, S.
    Biedermann, S.
    Wu, R.
    Mellis, S.
    Radin, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (10) : 1613 - 1617
  • [22] Effects of a Concomitant Single Oral Dose of Rifampicin on the Pharmacokinetics of Pravastatin in a Two-Phase, Randomized, Single-Blind, Placebo-Controlled, Crossover Study in Healthy Chinese Male Subjects
    Deng, Sheng
    Chen, Xiao-Ping
    Cao, Dan
    Yin, Tao
    Dai, Zhi-Yong
    Luo, Jian
    Tang, Ling
    Li, Yuan-Jian
    CLINICAL THERAPEUTICS, 2009, 31 (06) : 1256 - 1263
  • [23] SAMITAL® improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: results of a randomized, placebo-controlled, single-blind Phase II study
    D. Pawar
    R. S. Neve
    S. Kalgane
    A. Riva
    E. Bombardelli
    M. Ronchi
    G. Petrangolini
    P. Morazzoni
    Supportive Care in Cancer, 2013, 21 : 827 - 834
  • [24] SAMITAL® improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: results of a randomized, placebo-controlled, single-blind Phase II study
    Pawar, D.
    Neve, R. S.
    Kalgane, S.
    Riva, A.
    Bombardelli, E.
    Ronchi, M.
    Petrangolini, G.
    Morazzoni, P.
    SUPPORTIVE CARE IN CANCER, 2013, 21 (03) : 827 - 834
  • [25] Two year results from a double-blind, randomized, placebo-controlled study of adefovir dipivoxil (ADV) for presumed precore mutant chronic hepatitis B
    Hadziyannis, S
    Tassopoulos, N
    Heathcote, J
    Chang, TT
    Kitis, G
    Rizetto, M
    Marcellin, P
    Lim, SG
    Chen, SS
    Wulfsohn, M
    Wollman, M
    Fry, J
    Brosgart, C
    JOURNAL OF HEPATOLOGY, 2003, 38 : 143 - 143
  • [26] AZD0780, THE FIRST ORAL SMALL MOLECULE PCSK9 INHIBITOR FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA: RESULTS FROM A RANDOMIZED, SINGLE-BLIND, PLACEBO-CONTROLLED PHASE 1 TRIAL
    Vega, Rick
    Garkaviy, Pavlo
    Knochel, Jane
    Barbour, April
    Rudvik, Anna
    Laru, Johanna
    Twaddle, Lee
    Mccarthy, Michael C.
    Rosenmeier, Jaya Birgitte
    ATHEROSCLEROSIS, 2024, 395
  • [27] Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment
    Dodick, David W.
    Goadsby, Peter J.
    Lucas, Christian
    Jensen, Rigmor
    Bardos, Jennifer N.
    Martinez, James M.
    Zhou, Chunmei
    Aurora, Sheena K.
    Yang, Jyun Yan
    Conley, Robert R.
    Oakes, Tina
    CEPHALALGIA, 2020, 40 (09) : 935 - 948
  • [28] Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)
    T. Nakamura
    M. Fukunaga
    T. Nakano
    H. Kishimoto
    M. Ito
    H. Hagino
    T. Sone
    A. Taguchi
    S. Tanaka
    M. Ohashi
    Y. Ota
    M. Shiraki
    Osteoporosis International, 2017, 28 : 389 - 398
  • [29] Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)
    Nakamura, T.
    Fukunaga, M.
    Nakano, T.
    Kishimoto, H.
    Ito, M.
    Hagino, H.
    Sone, T.
    Taguchi, A.
    Tanaka, S.
    Ohashi, M.
    Ota, Y.
    Shiraki, M.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (01) : 389 - 398
  • [30] Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study
    Muzny, Christina A.
    Schwebke, Jane R.
    Nyirjesy, Paul
    Kaufman, Gregory
    Mena, Leandro A.
    Lazenby, Gweneth B.
    Van Gerwen, Olivia T.
    Graves, Keonte J.
    Arbuckle, Janeen
    Carter, Belvia A.
    McMahon, Connette P.
    Eder, Scott
    Shaw, Jackie
    Pandey, Brajesh
    Chavoustie, Steven E.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (06) : E1282 - E1289
12345